MedPath
NMPA Approval

氟脲嘧啶注射液

国药准字H20243002

January 5, 2024

Drug Information

氟脲嘧啶注射液

注射剂

10ml:0.5g

化学药品

January 5, 2024

Company Information

Applicant Company

武汉东湖新技术开发区高新大道858号生物医药园

Manufacturing Company

湖北省武汉东湖新技术开发区高新大道858号生物医药园A1-1

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氟脲嘧啶注射液 - NMPA 批准文号 | MedPath